- Malaysia
- /
- Medical Equipment
- /
- KLSE:ADVENTA
Adventa Berhad (KLSE:ADVENTA) Is Looking To Continue Growing Its Returns On Capital
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. With that in mind, we've noticed some promising trends at Adventa Berhad (KLSE:ADVENTA) so let's look a bit deeper.
Return On Capital Employed (ROCE): What Is It?
For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for Adventa Berhad, this is the formula:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
0.15 = RM10m ÷ (RM85m - RM16m) (Based on the trailing twelve months to June 2022).
Thus, Adventa Berhad has an ROCE of 15%. In isolation, that's a pretty standard return but against the Medical Equipment industry average of 20%, it's not as good.
See our latest analysis for Adventa Berhad
Historical performance is a great place to start when researching a stock so above you can see the gauge for Adventa Berhad's ROCE against it's prior returns. If you want to delve into the historical earnings, revenue and cash flow of Adventa Berhad, check out these free graphs here.
How Are Returns Trending?
Adventa Berhad has not disappointed in regards to ROCE growth. We found that the returns on capital employed over the last five years have risen by 576%. That's not bad because this tells for every dollar invested (capital employed), the company is increasing the amount earned from that dollar. Interestingly, the business may be becoming more efficient because it's applying 37% less capital than it was five years ago. If this trend continues, the business might be getting more efficient but it's shrinking in terms of total assets.
The Key Takeaway
From what we've seen above, Adventa Berhad has managed to increase it's returns on capital all the while reducing it's capital base. Investors may not be impressed by the favorable underlying trends yet because over the last five years the stock has only returned 7.6% to shareholders. So with that in mind, we think the stock deserves further research.
Adventa Berhad does have some risks though, and we've spotted 4 warning signs for Adventa Berhad that you might be interested in.
For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About KLSE:ADVENTA
Adventa Berhad
An investment holding company, engages in the supply of healthcare and related products and services to hospitals, healthcare centers, and pharmacies in Malaysia, Sri Lanka, Indonesia, and internationally.
Excellent balance sheet and fair value.